Toro Company (The) Common Stock vs UnitedHealth Group Inc — how do they compare? Toro Company (The) Common Stock trades at $98.27 (market cap $9.27B), while UnitedHealth Group Inc trades at $398.11 (market cap $339.08B). The key difference: UnitedHealth Group Inc is far larger — about 36.6× Toro Company (The) Common Stock's market cap, and UnitedHealth Group Inc pays the higher dividend (2.46%). Which is the better fit depends on your goals — on Pluang, investors hold Toro Company (The) Common Stock for 0 Days and UnitedHealth Group Inc for 98 Days on average.
| TTC | UNH | |
|---|---|---|
Market Cap | $9.27B | $339.08B |
Volume | 688,325 | 12,648,635 |
Sector | Industrials | Health |
52-Week High | $101.76 | $436.35 |
52-Week Low | $67.99 | $259.02 |
Typical Hold Time | 0 Days | 98 Days |
Enterprise Value | $10.17B | $380.94B |
Dividend Yield | 1.59% | 2.46% |
Signals from Pluang's Aura AI — not financial advice
Toro Company (TTC) trades at $97.88, up 1.27% with strong technical momentum above its 50-day moving average. The company demonstrates solid fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.33 beating expectations of $1.31, and raised full-year guidance. Revenue growth of 8.4% in Q3 2026 to $1.23 billion reflects robust demand across professional and residential segments, supported by infrastructure and automation initiatives under new CEO leadership.
Toro presents a balanced investment case with 36% analyst buy ratings and $117.50 price target suggesting 20% upside. However, execution risks from inflation, tariffs, and competitive pressures warrant caution. The stock's premium valuation (P/E 26.17) requires sustained earnings growth, making Q3 2026 results critical for validating current momentum.
UnitedHealth Group (UNH) trades at $377.76, down 0.2% on the day, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $6.38 surpassing the $4.91 expectation. Revenue reached $447.57 billion in 2025, though net income margin declined to 2.69%. Recent news highlights dividend payments and strategic moves like the TPG deal for WellMed clinics.
UNH presents a favorable outlook with a consensus price target of $470.11, implying significant upside. Strengths include robust cash flow, a dominant market position, and AI investments in Optum. Risks involve regulatory pressures, rising medical costs, and debt levels. The stock remains a core holding for growth-oriented investors seeking healthcare exposure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The Toro Company designs, manufactures, and markets equipment for turf maintenance, snow and ice management, landscaping, construction, and irrigation. Its products serve golf courses, sports fields, and residential and commercial properties in more than 125 countries.
Read more on TTC →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →